[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2017170502A1 - Syringe - Google Patents

Syringe Download PDF

Info

Publication number
WO2017170502A1
WO2017170502A1 PCT/JP2017/012563 JP2017012563W WO2017170502A1 WO 2017170502 A1 WO2017170502 A1 WO 2017170502A1 JP 2017012563 W JP2017012563 W JP 2017012563W WO 2017170502 A1 WO2017170502 A1 WO 2017170502A1
Authority
WO
WIPO (PCT)
Prior art keywords
syringe
cover member
tip
barrel
distal end
Prior art date
Application number
PCT/JP2017/012563
Other languages
French (fr)
Japanese (ja)
Inventor
竹本昌史
Original Assignee
テルモ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テルモ株式会社 filed Critical テルモ株式会社
Priority to JP2018508045A priority Critical patent/JPWO2017170502A1/en
Publication of WO2017170502A1 publication Critical patent/WO2017170502A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/32Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles

Definitions

  • the present invention relates to a syringe provided with a protection device.
  • a syringe used for administration of a medical solution or the like to a patient which includes a protective device for preventing inadvertent puncture due to exposure of a puncture needle before and after puncture (for example, a special table) (See 2011-513035).
  • a protective device for preventing inadvertent puncture due to exposure of a puncture needle before and after puncture (for example, a special table) (See 2011-513035).
  • a protective device has a cover member that is axially displaceable relative to the barrel of the syringe. Before the puncture, the cover member covers the needle tip of the puncture needle. The cover member is displaced in the proximal direction with respect to the barrel by being pushed by the skin as the puncture needle punctures the skin.
  • a user such as a doctor may puncture the puncture needle obliquely with respect to the skin depending on the user's preference or the like.
  • the front end portion of the cover member comes into contact with the skin obliquely before the puncture needle is punctured into the skin, so that the cover member is easy to slide against the skin. Therefore, it may be difficult to puncture the target site with the puncture needle.
  • the present invention has been made in consideration of such problems, and provides a syringe capable of suppressing the sliding of the cover member with respect to the skin when the puncture needle is punctured obliquely with respect to the skin. For the purpose.
  • the syringe of the present invention is a barrel, a puncture needle that protrudes from the distal end portion of the barrel in the distal direction and has a needle tip at the distal end, and is axially displaceable with respect to the barrel.
  • the cover member has a hollow cylindrical cover member, and the cover member covers at least a part of the puncture needle in an initial state, and is pressed against the puncture target when the puncture needle is punctured to the puncture target.
  • a protection device configured to cover the needle tip with the cover member after the puncture needle is punctured into the puncture target.
  • the distal end portion is provided with a slip suppressing portion that extends in a circumferential direction and suppresses slipping on the puncture target when the cover member is in contact with the puncture target at an angle. .
  • the slip suppression portion is provided at the distal end portion of the cover member, even when the cover member is contacted obliquely with respect to the puncture target, the cover member is It is possible to effectively suppress sliding with respect to the puncture target.
  • the slip prevention part may be formed in an annular shape.
  • the slip suppression portion may have a protruding structure that protrudes radially outward from the cover member.
  • the protrusion structure bites into the puncture target at the time of contact with the puncture target, thereby providing a slip suppression function with a simple configuration.
  • the protruding structure may protrude from the outer peripheral surface of the cover member.
  • This configuration can more effectively exhibit the slip suppression function.
  • the protrusion structure may have a plurality of protrusions arranged in the axial direction.
  • This configuration provides a better slip suppression function.
  • the protrusions adjacent to each other in the plurality of protrusions may protrude outward in the radial direction from the protrusion on the proximal end side than the protrusion on the distal end side.
  • the protruding structure may have a tip surface perpendicular to the axial direction.
  • This configuration provides a good slip suppression function.
  • the cover member may have a curved surface on the distal end side with respect to the protruding structure, the outer diameter of which decreases in the distal direction.
  • the cover member includes a cover member main body and the slip suppression portion fixed to a distal end portion of the cover member main body, and the slip suppression portion is an elastic member made of an elastic material. There may be.
  • the elastic member may be fixed to a distal end surface of the cover member main body.
  • the elastic member may cover the distal end portion of the cover member main body from the outer peripheral surface to the distal end surface.
  • the elastic member may have a concave portion that engages with a convex portion provided on the inner peripheral portion of the tip of the cover member body, and may be fitted inside the tip portion of the cover member body.
  • the elastic member can be easily assembled to the cover member main body in the assembly process.
  • the elastic member may be fitted into a groove provided at a distal end portion of the cover member main body and protrude from an outer peripheral surface of the distal end portion.
  • the cover member when the puncture needle is punctured obliquely with respect to the skin, the cover member can be prevented from sliding with respect to the skin.
  • proximal end refers to an end portion on the side close to the user who operates the syringe
  • tip refers to an end portion on the side away from the user.
  • the syringe 10A is configured as a prefilled syringe that is pre-filled with a chemical M in a product provision state.
  • the syringe 10A includes a hollow barrel 12, a drug solution M filled in the barrel 12, a puncture needle 14 protruding from the distal end portion of the barrel 12 in the distal direction, a gasket 16 inserted into the barrel 12, and a gasket.
  • 16 includes a pusher 18 connected to 16 and a protection device 20 attached to the barrel 12.
  • the barrel 12 is a hollow body having a substantially cylindrical barrel body 22 and a proximal end opening at the proximal end.
  • a flange 24 is formed on the outer peripheral portion of the base end of the barrel body 22 so as to protrude outward in the radial direction.
  • a needle holder 26 is provided at the tip of the barrel body 22.
  • the needle holding part 26 is reduced in diameter with respect to the barrel body part 22 and extends in the distal direction, and holds the proximal end part of the puncture needle 14.
  • the flange 24 and the needle holding part 26 are formed integrally with the barrel body part 22.
  • a gasket 16 is inserted through a base end opening.
  • the proximal end side of the barrel 12 is liquid-tightly sealed by the gasket 16, and the chemical solution M is sealed in the barrel 12.
  • the gasket 16 is arranged so that its outer peripheral portion is in liquid-tight contact with the inner peripheral surface of the barrel 12 and is slidable in the barrel 12.
  • the tip of a pusher 18 is connected to the gasket 16.
  • the pusher 18 may be connected to the gasket 16 when the patient is punctured with the puncture needle 14 and the medicinal solution M is administered to the patient.
  • the puncture needle 14 is a hollow body in which a lumen as a fluid passage is formed, and a sharp needle tip 15 is formed at the tip thereof.
  • the puncture needle 14 protrudes from the needle holding portion 26 in the distal direction.
  • the lumen of the puncture needle 14 communicates with the hollow portion (liquid chamber) of the barrel 12 through the proximal end opening of the puncture needle 14.
  • the puncture needle 14 is fixed and held at the center of the needle holding part 26.
  • the drug solution M accommodated in the hollow interior of the barrel 12 is discharged from the distal end of the lumen of the puncture needle 14 and administered to the patient.
  • the protection device 20 covers the puncture needle 14 before and after the puncture of the puncture needle 14 to the patient, thereby preventing inadvertent punctures other than when the drug solution M is administered to the patient. is there.
  • the protection device 20 includes at least a hollow cylindrical cover member 28 that can be displaced relative to the barrel 12 in the axial direction.
  • the cover member 28 has a distal end located closer to the distal end than the needle tip 15 of the puncture needle 14 and covers the needle tip 15.
  • the cover member 28 is relatively displaced in the proximal direction with respect to the barrel 12 when the puncture needle 14 is punctured to the patient to be punctured, and the puncture needle 14 protrudes in the distal direction from the distal opening 29 of the cover member 28 (FIG. 4).
  • the cover member 28 is displaced relative to the barrel 12 in the distal direction after puncturing, and covers the needle tip 15 of the puncture needle 14 again.
  • the needle tip 15 of the puncture needle 14 may protrude from the distal end opening 29 of the cover member 28 in the distal direction.
  • the constituent material of the cover member 28 is not particularly limited, and examples thereof include resin materials such as polypropylene, polycarbonate, polyamide, polysulfone, polyarylate, ABS, and high-density polyethylene.
  • the configuration of the protection device 20 provided with the cover member 28 acting in this way is not limited to a specific configuration, and can take various forms. Therefore, the protection device 20 may be configured as described below, for example, or may be configured in another form.
  • the protection device 20 includes an inner member rotatably attached to the outer periphery of the needle holding portion 26, a cover member 28 that is movable in the axial direction relative to the inner member, and biases the cover member 28 in the distal direction.
  • a spring member biasing member
  • a cam protrusion protruding radially outward is formed on the outer peripheral portion of the inner member.
  • the cover member 28 is formed of a hollow body having a side wall that forms a through hole extending from the front end to the base end, and the inner member is accommodated in the through hole.
  • a guide path is formed on the side wall of the cover member 28, and the cam projection of the inner member is movably disposed in the guide path.
  • the spring member is accommodated in the through hole of the cover member 28, and biases the cover member 28 in the distal direction with respect to the inner member.
  • the cover member 28 in the guide path, is relatively displaced in the proximal direction with respect to the barrel 12 from the initial position with the puncture operation of the puncture needle 14 to the patient, and is guided to the retracted position.
  • 14 may be configured to be relatively displaced in the distal direction with respect to the barrel 12 from the retracted position in accordance with the extraction operation 14 and guided to the lock position.
  • the cover member 28 covers the needle tip 15 of the puncture needle 14 at the initial position.
  • the puncture needle 14 is protruded from the distal end opening 29 at the retracted position, and the needle tip 15 of the puncture needle 14 is covered at the locked position.
  • the cover member 28 moves from the initial position to the retracted position, the spring member is compressed in the axial direction.
  • the cover member 28 is moved from the retracted position to the locked position by the elastic biasing force of the spring member when the puncture needle 14 is removed.
  • the needle tip 15 may be exposed (protruded) from the tip opening 29 of the cover member 28.
  • the inner member moves relative to the cover member 28 by the cam protrusion moving in the guide path. Rotate to.
  • the inner member restricts relative displacement of the cover member 28 in the proximal direction with respect to the inner member when the cover member 28 moves to the lock position.
  • a cap (not shown) made of a flexible resin material such as an elastomer covers the puncture needle 14.
  • the cap is inserted into the cover member 28 so as to cover the puncture needle 14 so as to seal the needle tip 15 (the distal end opening of the puncture needle 14).
  • the cap is removed by the user pulling the tip and pulling it in the direction of the tip.
  • a slip suppression unit 30 is provided.
  • the slip suppression unit 30 extends in the circumferential direction.
  • the slip suppression unit 30 includes a protruding structure 32 protruding from the cover member 28.
  • the protruding structure 32 is formed in an annular shape that protrudes radially outward from the outer peripheral surface of the cover member 28 and makes a round in the circumferential direction of the cover member 28.
  • the protruding structure 32 is formed integrally with the cover member 28.
  • the protruding structure 32 has a tip surface 33 that is substantially perpendicular to the axial direction of the cover member 28.
  • tip part of the protrusion structure 32 may be a taper outer surface where an outer diameter increases as it goes to a base end direction.
  • a V-shaped groove that is recessed in the proximal direction may be provided at the distal end portion of the protruding structure 32.
  • the cover member 28 has a tip annular contact portion 34 having a curved surface 35 whose outer diameter decreases toward the tip direction on the tip side of the protrusion structure 32.
  • the tip annular contact portion 34 surrounds the tip opening 29 and is formed so as to protrude in the tip direction with respect to the protruding structure 32.
  • the outer diameter of the protrusion structure 32 is larger than the maximum outer diameter of the tip annular contact portion 34.
  • the protruding height in the radial direction of the protrusion structure 32 from the tip annular contact portion 34 is, for example, 0.3 to 5 mm, and preferably 0.5 to 2 mm.
  • the protrusion height of the protrusion structure 32 is one half of the difference between the outer diameter of the tip annular contact portion 34 and the outer diameter of the protrusion structure 32.
  • the user When administering the drug solution M to the patient, the user (which may be the patient himself) first connects the pusher 18 to the gasket 16 to obtain the state shown in FIG. As shown in FIG. 1, the syringe 10 ⁇ / b> A may be provided to the user in a state where the pusher 18 is connected to the gasket 16 in advance.
  • the user pulls out the cap from the cover member 28 by grasping and pulling the cap (not shown).
  • the cover member 28 is biased to the initial position (pre-puncture position) by the elastic biasing force of the spring member described above, and the puncture needle 14 is surrounded by the cover member 28 up to the tip 15 of the tip. It is kept. This prevents the puncture needle 14 from being punctured carelessly by a user or the like.
  • the user presses the distal end portion of the cover member 28 against the patient's puncture site (skin S such as an arm) to position the distal end portion of the cover member 28.
  • the user may want to puncture the puncture needle 14 obliquely with respect to the skin S according to the preference or situation.
  • the cover member 28 comes into contact with the skin S in a state where the axial direction is oblique with respect to the skin S. That is, in the cover member 28, the annular tip surface does not contact the skin S, but only a part of the tip portion in the circumferential direction contacts the skin S.
  • the cover member 28 since the protruding structure 32 provided at the tip of the cover member 28 bites into the skin S, the cover member 28 is prevented from sliding with respect to the skin S. Therefore, the cover member 28 can be easily held at the positioned position.
  • the cover member 28 resists the elastic biasing force of the spring member against the barrel 12. Relative displacement in the proximal direction. With such relative displacement, as shown in FIG. 4, the puncture needle 14 is exposed from the distal end opening 29 of the cover member 28 and is punctured by the patient.
  • the user presses the pusher 18 shown in FIG. 1 in the distal direction with the puncture needle 14 being punctured by the patient.
  • the drug solution M filled in the barrel 12 is discharged from the puncture needle 14 via the lumen of the puncture needle 14.
  • the drug solution M is administered to the patient.
  • the cover member 28 When the user pulls the cover member 28 together with the syringe 10A from the patient to remove the puncture needle 14 from the patient after the administration of the medicinal solution M, the cover member 28 is moved in the distal direction with respect to the barrel 12 by the elastic biasing force of the spring member. The needle tip 15 of the puncture needle 14 is covered with relative displacement. Thereby, inadvertent puncture can be avoided even after administration of the drug solution M to the patient.
  • the slip suppression portion 30 is provided at the distal end portion of the cover member 28, the cover member 28 is brought into contact with the puncture target obliquely. Even in this case, the sliding of the cover member 28 with respect to the puncture target can be effectively suppressed. Therefore, the puncture needle 14 can be punctured accurately at the target site.
  • the slip suppression portion 30 is formed in an annular shape, it is possible to exert a slip suppression effect regardless of the circumferential position of the cover member 28 with respect to the puncture target.
  • the slip suppression unit 30 since the slip suppression unit 30 has the protrusion structure 32 protruding from the cover member 28, the protrusion structure 32 bites into the puncture target at the time of contact with the puncture target, thereby providing a slip suppression function with a simple configuration. can get.
  • the slip suppression function can be more effectively exhibited.
  • the cover member 28 has a curved surface whose outer diameter decreases in the distal direction from the protrusion structure 32, so that the slippage is suppressed while suppressing stimulation at the time of contact with the puncture target. be able to. Thereby, it is possible to prevent the pain and discomfort given to the patient during puncturing from increasing.
  • the slip suppression unit 30 that suppresses slipping with respect to the puncture target when the cover member 28 obliquely contacts the puncture target at the distal end portion of the cover member 28.
  • the protrusion structure 40 is integrally provided.
  • the protruding structure 40 is formed in an annular shape that protrudes radially outward from the outer peripheral surface of the cover member 28 and makes a round in the circumferential direction of the cover member 28.
  • the protrusion structure 40 has a plurality (three in the illustrated example) of protrusions arranged in the axial direction. Specifically, the protrusion structure 40 is provided on the proximal end side of the annular first protrusion 42, the annular second protrusion 44 provided on the proximal end side with respect to the first protrusion 42, and the second protrusion 44. And an annular third protrusion 46.
  • the adjacent protrusions of the plurality of protrusions are such that the proximal protrusion protrudes radially outward than the distal protrusion. Therefore, in the syringe 10 ⁇ / b> B, the outer diameter of the second protrusion 44 is larger than the outer diameter of the first protrusion 42. The outer diameter of the third protrusion 46 is larger than the outer diameter of the second protrusion 44.
  • the first protrusion 42, the second protrusion 44, and the third protrusion 46 have front end surfaces 42a, 44a, 46a substantially perpendicular to the axial direction of the cover member 28, respectively.
  • tip part of the 1st protrusion 42, the 2nd protrusion 44, and the 3rd protrusion 46 may each be a taper outer surface where an outer diameter increases as it goes to a base end direction.
  • V-shaped grooves that are recessed in the proximal direction may be provided at the distal ends of the first protrusion 42, the second protrusion 44, and the third protrusion 46, respectively.
  • the configuration of the other parts of the syringe 10B is the same as that of the syringe 10A according to the first embodiment.
  • the syringe 10B including the protruding structure 40 configured as described above also applies the cover member 28 obliquely to the skin S of the patient to be punctured.
  • the sliding of the cover member 28 with respect to the skin S when contacted can be effectively suppressed.
  • the protrusion structure 40 has a plurality of protrusions (first protrusion 42, second protrusion 44, and third protrusion 46) arranged in the axial direction, a better slip suppression function can be obtained. . Further, since the adjacent protrusions of the plurality of protrusions protrude outward in the radial direction from the protrusion on the distal end side, the protrusions on the proximal end side of the adjacent protrusions also bite into the skin S. In addition, the slip prevention function can be surely exhibited.
  • the syringe 10C according to the third embodiment shown in FIG. 6 is provided with an elastic member 52a made of an elastic material (elastomer) instead of the protruding structure 32 in the syringe 10A according to the first embodiment. . That is, an elastic member 52a is provided at the distal end portion of the cover member 28a as the slip suppression portion 30 that suppresses slipping on the skin S when the cover member 28a obliquely contacts the skin S that is the puncture target. ing.
  • the cover member 28 a includes a cover member main body 48 and an elastic member 52 a attached to the tip of the cover member main body 48.
  • the cover member main body 48 corresponds to the cover member 28 in the first embodiment in which the protruding structure 32 is eliminated.
  • Examples of the elastic material constituting the elastic member 52a include various rubber materials such as natural rubber, butyl rubber, isoprene rubber, butadiene rubber, styrene-butadiene rubber, and silicone rubber, polyurethane, polyester, polyamide, and olefin. , Various thermoplastic elastomers such as styrene, or a mixture thereof.
  • the elastic member 52 a is formed in an annular shape along the circular front end surface of the cover member main body 48.
  • a recess 55 is provided on the base end surface of the elastic member 52a.
  • a protrusion 57 protruding in the distal direction is provided on the distal end surface of the cover member 28a.
  • the elastic member 52 a is fixed to the cover member main body 48 by fitting the projection 57 into the concave portion 55.
  • protrusion 57 may each be provided cyclically
  • the hole 53 of the elastic member 52a communicates with the tip opening 29 of the cover member 28a. In FIG.
  • the diameter of the hole 53 (the inner diameter of the elastic member 52 a) is slightly larger than the diameter of the tip opening 29 of the cover member main body 48.
  • the diameter of the hole 53 may be the same as or smaller than the diameter of the tip opening 29 of the cover member 28 a.
  • the friction coefficient between the elastic member 52a and the skin S is larger than the friction coefficient between the cover member main body 48 and the skin S. Therefore, the elastic member 52 a is less slidable with respect to the skin S than the cover member main body 48.
  • the other parts of the syringe 10C are configured in the same manner as the syringe 10A according to the first embodiment.
  • the cover member 28a in order to position the cover member 28a with respect to the skin S in a state where the needle tip 15 of the puncture needle 14 is covered with the cover member 28a,
  • the elastic member 52a provided at the most distal end of the syringe 10C comes into contact with the skin S. Therefore, even when the cover member 28a is brought into contact with the skin S at an angle, the elastic member 52a prevents the cover member 28a from sliding on the skin S. Therefore, the cover member 28a can be easily held at a position where it is desired to position.
  • the cover member 28a when the cover member 28a is obliquely brought into contact with the skin S of the patient that is the puncture target, the cover member 28a is also provided by the syringe 10C, similarly to the syringe 10A according to the first embodiment described above. Can be effectively suppressed from slipping on the skin S.
  • the slip suppression unit 30 is an elastic member 52a made of an elastic material, so that a favorable slip suppression function can be obtained while suppressing irritation at the time of contact with the skin S. Further, since the elastic member 52a is fixed to the distal end surface of the cover member main body 48, the elastic member 52a can be easily provided at the distal end portion of the cover member 28a.
  • the cover member 28a of the syringe 10D according to the fourth embodiment shown in FIG. 7 includes a cover member main body 48 and an elastic member 52b made of an elastic material fixed to the distal end portion of the cover member main body 48.
  • the elastic member 52b functions as a slip suppression unit 30 that suppresses slipping on the skin S when the cover member 28a obliquely contacts the skin S that is the puncture target.
  • the elastic member 52b can be made of the same material as the elastic member 52a in the third embodiment.
  • the elastic member 52b is formed in an annular shape.
  • the elastic member 52b covers the distal end portion of the cover member main body 48 from the outer peripheral surface 48a to the distal end surface 48b.
  • the elastic member 52b has a hole 53 that communicates with the tip opening 29 of the cover member 28a.
  • an engagement protrusion 56 that protrudes radially inward is provided on the inner peripheral surface of the elastic member 52b.
  • the engagement protrusion 56 is an annular protrusion that extends in the circumferential direction.
  • the engaging protrusions 56 may be a plurality of protrusions provided at intervals in the circumferential direction.
  • tip part of the cover member main body 48 is provided with the engaging groove 58 dented to radial inside.
  • the engagement groove 58 is an annular groove extending in the circumferential direction.
  • the engagement groove 58 may be a plurality of grooves provided at intervals in the circumferential direction.
  • the elastic member 52 b is fixed to the distal end portion of the cover member main body 48 by the engagement protrusion 56 and the engagement groove 58 engaging with each other.
  • the elastic member 52 b includes a peripheral wall portion 60 that surrounds the outer peripheral surface 48 a of the distal end portion of the cover member main body 48, and a distal end curved portion 62 that curves radially inward from the distal end of the peripheral wall portion 60 and surrounds the hole portion 53.
  • the outer diameter and inner diameter of the peripheral wall portion 60 decrease toward the distal end direction.
  • the outer diameter and inner diameter of the peripheral wall portion 60 may be constant in the axial direction.
  • the inner peripheral surface 60 a of the peripheral wall portion 60 is in contact with the outer peripheral surface 48 a of the tip portion of the cover member main body 48.
  • the proximal end surface 62 a of the distal end bending portion 62 is in contact with the distal end surface 48 b of the distal end portion of the cover member main body 48.
  • the other parts of the syringe 10D are configured in the same manner as the syringe 10A according to the first embodiment.
  • the syringe 10D including the elastic member 52b configured as described above also has the cover member 28a obliquely brought into contact with the skin S of the patient to be punctured. In addition, it is possible to effectively prevent the cover member 28a from slipping on the puncture target. Moreover, in this syringe 10D, since the slip suppression part 30 is the elastic member 52b comprised with the elastic material, a favorable slip suppression function is obtained, suppressing the irritation
  • the elastic member 52b covers the distal end portion of the cover member main body 48 from the outer peripheral surface 48a to the distal end surface 48b, and therefore the puncture target regardless of the puncture angle of the puncture needle 14 with respect to the puncture target. Can be effectively suppressed.
  • the cover member 28a of the syringe 10E according to the fifth embodiment shown in FIG. 8 includes a cover member main body 48 and an elastic member 52c made of an elastic material fixed to the distal end portion of the cover member main body 48.
  • the elastic member 52c functions as the slip suppression unit 30 that suppresses slipping on the puncture target when the cover member 28a is in contact with the puncture target at an angle.
  • the elastic member 52c can be made of the same material as the elastic member 52a in the third embodiment.
  • the elastic member 52 c is formed in an annular shape, and has a hole 63 that penetrates in the axial direction and communicates with the inner cavity of the cover member main body 48.
  • the puncture needle 14 can project in the distal direction of the cover member 28a through the hole 63.
  • the elastic member 52c has a concave portion 66 that engages with the convex portion 64 provided on the inner peripheral portion of the front end of the cover member main body 48, and is fitted inside the front end portion of the cover member 28a.
  • the recess 66 is formed in an annular shape that is recessed inward in the radial direction from the outer peripheral surface of the elastic member 52c and extends once in the circumferential direction.
  • the convex portion 64 is formed in an annular shape that protrudes inward in the radial direction and extends around the circumference in the circumferential direction.
  • the elastic member 52 c is fixed to the distal end portion of the cover member main body 48 by engaging the concave portion 66 and the convex portion 64.
  • the syringe 10E provided with the elastic member 52c configured as described above also causes the cover member 28a to be in contact with the skin S of the patient to be punctured obliquely.
  • the sliding of the cover member 28a with respect to the skin S can be effectively suppressed.
  • the slip suppression part 30 is the elastic member 52c comprised with the elastic material, a favorable slip suppression function is obtained, suppressing the irritation
  • the elastic member 52c has a concave portion 66 that engages with the convex portion 64 provided on the inner peripheral portion of the front end of the cover member main body 48, and fits inside the front end portion of the cover member main body 48. Therefore, the elastic member 52c can be easily assembled to the cover member main body 48 in the assembly process.
  • the cover member 28a of the syringe 10F includes a cover member main body 48 and an elastic member 52d made of an elastic material fixed to the distal end portion of the cover member main body 48.
  • the elastic member 52d functions as the slip suppression unit 30 that suppresses slipping on the skin S when the cover member 28a is in contact with the skin S that is a puncture target obliquely.
  • the elastic member 52d can be made of the same material as the elastic member 52a in the third embodiment.
  • the elastic member 52d is formed in an annular shape surrounding the tip of the cover member main body 48.
  • the elastic member 52 d is fitted in a groove 68 provided at the tip of the cover member main body 48.
  • the elastic member 52d is fixed to the tip of the cover member main body 48 by fitting the inner peripheral portion of the elastic member 52d into the groove 68.
  • the elastic member 52d protrudes radially outward from the outer peripheral surface 48a of the front end portion of the cover member main body 48.
  • the groove portion 68 is formed in an annular shape that is recessed radially inward from the outer peripheral surface 48a of the distal end portion of the cover member main body 48 and extends one round in the circumferential direction.
  • the cover member 28a when the cover member 28a is obliquely brought into contact with the skin S of the patient to be punctured, as in the syringes 10A to 10E described above, the cover member 28a is It is possible to effectively suppress sliding with respect to the puncture target. Moreover, in this syringe 10F, since the slip suppression part 30 is the elastic member 52d comprised with the elastic material, a favorable slip suppression function is obtained, suppressing the irritation
  • the elastic member 52d is fitted into the groove 68 provided at the distal end portion of the cover member main body 48 and protrudes from the outer peripheral surface 48a of the distal end portion of the cover member main body 48.
  • the amount of material used can be suppressed.
  • the elastic member 52d can be easily assembled to the cover member main body 48.
  • the protrusion structure 32 (FIG. 2) or the protrusion structure 40 (FIG. 5) may be integrally provided on the outer periphery of the elastic members 52a to 52d.
  • the protruding structures 32 and 40 are made of an elastic material.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

A syringe (10A) is provided with a barrel (12), a needle (14) protruding from the barrel (12), and a protective device (20) comprising a cover member (28) that is capable of relative axial displacement with respect to the barrel (12) and covers the needle tip (15) after the needle (14) has been inserted into a subject. An anti-slip member (30) that extends in the circumferential direction is provided at the distal end of the cover member (28) to prevent slippage once the cover member (28) has obliquely contacted the subject. The anti-slip part (30) comprises, for example, a projecting structure (32).

Description

注射器Syringe
 本発明は、保護装置を備えた注射器に関する。 The present invention relates to a syringe provided with a protection device.
 患者への薬液等の投与のために使用される注射器においては、穿刺前後に穿刺針の露出による不用意な穿刺を防止するための保護装置を備えたものが知られている(例えば、特表2011-513035号公報を参照)。このような保護装置は、注射器のバレルに対して軸方向に相対変位可能なカバー部材を有する。穿刺前においてカバー部材は穿刺針の針先を覆っている。カバー部材は、穿刺針の皮膚への穿刺に伴って皮膚に押されることでバレルに対して基端方向に変位する。 2. Description of the Related Art A syringe used for administration of a medical solution or the like to a patient is known which includes a protective device for preventing inadvertent puncture due to exposure of a puncture needle before and after puncture (for example, a special table) (See 2011-513035). Such a protective device has a cover member that is axially displaceable relative to the barrel of the syringe. Before the puncture, the cover member covers the needle tip of the puncture needle. The cover member is displaced in the proximal direction with respect to the barrel by being pushed by the skin as the puncture needle punctures the skin.
 保護装置を備えた注射器を用いて患者に薬液等を投与する際、医師等のユーザは、ユーザの好み等により、皮膚に対して斜めに穿刺針を穿刺する場合がある。このような場合、カバー部材の先端部は、穿刺針が皮膚に穿刺される前に、皮膚に対して斜めに当接することになるため、カバー部材が皮膚に対して滑りやすい。従って、狙った部位に穿刺針を穿刺しにくい場合がある。 When a medical solution or the like is administered to a patient using a syringe equipped with a protective device, a user such as a doctor may puncture the puncture needle obliquely with respect to the skin depending on the user's preference or the like. In such a case, the front end portion of the cover member comes into contact with the skin obliquely before the puncture needle is punctured into the skin, so that the cover member is easy to slide against the skin. Therefore, it may be difficult to puncture the target site with the puncture needle.
 本発明はこのような課題を考慮してなされたものであり、皮膚に対して斜めに穿刺針を穿刺するときに、カバー部材が皮膚に対して滑ることを抑制することができる注射器を提供することを目的とする。 The present invention has been made in consideration of such problems, and provides a syringe capable of suppressing the sliding of the cover member with respect to the skin when the puncture needle is punctured obliquely with respect to the skin. For the purpose.
 上記の目的を達成するため、本発明の注射器は、バレルと、前記バレルの先端部から先端方向に突出し、先端に針先を有する穿刺針と、前記バレルに対して軸方向に相対変位可能な中空筒状のカバー部材を有し、初期状態で前記カバー部材が前記穿刺針の少なくとも一部を覆い、穿刺対象への前記穿刺針の穿刺時に前記穿刺対象に対して押しつけられることで前記カバー部材が前記バレルに対して基端方向に相対変位し、前記穿刺対象への前記穿刺針の穿刺後に前記カバー部材により前記針先を覆うように構成された保護装置と、を備え、前記カバー部材の先端部には、周方向に延在し、前記カバー部材が前記穿刺対象に対して斜めに当接したときに前記穿刺対象に対する滑りを抑制する滑り抑制部が設けられていることを特徴とする。 In order to achieve the above object, the syringe of the present invention is a barrel, a puncture needle that protrudes from the distal end portion of the barrel in the distal direction and has a needle tip at the distal end, and is axially displaceable with respect to the barrel. The cover member has a hollow cylindrical cover member, and the cover member covers at least a part of the puncture needle in an initial state, and is pressed against the puncture target when the puncture needle is punctured to the puncture target. And a protection device configured to cover the needle tip with the cover member after the puncture needle is punctured into the puncture target. The distal end portion is provided with a slip suppressing portion that extends in a circumferential direction and suppresses slipping on the puncture target when the cover member is in contact with the puncture target at an angle. .
 上記の構成を採用した本発明の注射器によれば、カバー部材の先端部に滑り抑制部が設けられているため、穿刺対象に対してカバー部材を斜めに当接させた場合でも、カバー部材が穿刺対象に対して滑ることを効果的に抑制することができる。 According to the syringe of the present invention that employs the above configuration, since the slip suppression portion is provided at the distal end portion of the cover member, even when the cover member is contacted obliquely with respect to the puncture target, the cover member is It is possible to effectively suppress sliding with respect to the puncture target.
 上記の注射器において、前記滑り抑制部は、環状に形成されていてもよい。 In the above syringe, the slip prevention part may be formed in an annular shape.
 この構成により、穿刺対象に対するカバー部材の周方向位置に関わらず、滑り抑制効果を発揮することができる。 With this configuration, a slip suppression effect can be exhibited regardless of the circumferential position of the cover member with respect to the puncture target.
 上記の注射器において、前記滑り抑制部は、前記カバー部材から径方向外側に突出した突起構造を有してもよい。 In the above syringe, the slip suppression portion may have a protruding structure that protrudes radially outward from the cover member.
 この構成により、穿刺対象との接触時に突起構造が穿刺対象に食い込むことにより、簡易構成で滑り抑制機能が得られる。 With this configuration, the protrusion structure bites into the puncture target at the time of contact with the puncture target, thereby providing a slip suppression function with a simple configuration.
 上記の注射器において、前記突起構造は、前記カバー部材の外周面から突出していてもよい。 In the above syringe, the protruding structure may protrude from the outer peripheral surface of the cover member.
 この構成により、滑り抑制機能を一層効果的に発揮することができる。 This configuration can more effectively exhibit the slip suppression function.
 上記の注射器において、前記突起構造は、軸方向に並んだ複数の突起を有していてもよい。 In the above syringe, the protrusion structure may have a plurality of protrusions arranged in the axial direction.
 この構成により、一層良好な滑り抑制機能が得られる。 This configuration provides a better slip suppression function.
 上記の注射器において、前記複数の突起において隣り合う突起は、先端側の突起よりも基端側の突起の方が径方向外側に突出していてもよい。 In the above-described syringe, the protrusions adjacent to each other in the plurality of protrusions may protrude outward in the radial direction from the protrusion on the proximal end side than the protrusion on the distal end side.
 この構成により、隣り合う突起における基端側の突起についても穿刺対象に食い込ませ、滑り抑制機能を確実に発揮することができる。 With this configuration, it is possible to cause the protrusion on the proximal end side of adjacent protrusions to bite into the puncture target and to reliably exhibit the slip suppression function.
 上記の注射器において、前記突起構造は、軸方向に対して垂直な先端面を有していてもよい。 In the above syringe, the protruding structure may have a tip surface perpendicular to the axial direction.
 この構成により、良好な滑り抑制機能が得られる。 This configuration provides a good slip suppression function.
 上記の注射器において、前記カバー部材は、前記突起構造よりも先端側に、先端方向に向かう従って外径が減少する湾曲面を有していてもよい。 In the above-described syringe, the cover member may have a curved surface on the distal end side with respect to the protruding structure, the outer diameter of which decreases in the distal direction.
 この構成により、穿刺対象に対する接触時の刺激を抑制しつつ滑りを抑制することができる。 With this configuration, it is possible to suppress slipping while suppressing irritation upon contact with the puncture target.
 上記の注射器において、前記カバー部材は、カバー部材本体と、前記カバー部材本体の先端部に固定された前記滑り抑制部とを有し、前記滑り抑制部は、弾性材料により構成された弾性部材であってもよい。 In the above syringe, the cover member includes a cover member main body and the slip suppression portion fixed to a distal end portion of the cover member main body, and the slip suppression portion is an elastic member made of an elastic material. There may be.
 これにより、穿刺対象に対する接触時の刺激を抑制しつつ良好な滑り抑制機能が得られる。 This makes it possible to obtain a good slip suppression function while suppressing irritation upon contact with the puncture target.
 上記の注射器において、前記弾性部材は、前記カバー部材本体の先端面に固定されていてもよい。 In the above syringe, the elastic member may be fixed to a distal end surface of the cover member main body.
 これにより、カバー部材本体の先端部に弾性部材を簡単に設けることができる。 This makes it possible to easily provide an elastic member at the tip of the cover member body.
 上記の注射器において、前記弾性部材は、前記カバー部材本体の前記先端部を外周面から先端面に亘って覆っていてもよい。 In the above syringe, the elastic member may cover the distal end portion of the cover member main body from the outer peripheral surface to the distal end surface.
 この構成により、穿刺対象に対する穿刺針の穿刺角度に関わらず、滑りを効果的に抑制することができる。 With this configuration, slippage can be effectively suppressed regardless of the puncture angle of the puncture needle with respect to the puncture target.
 上記の注射器において、前記弾性部材は、前記カバー部材本体の先端内周部に設けられた凸部と係合する凹部を有し、前記カバー部材本体の先端部内側に嵌合していてもよい。 In the above syringe, the elastic member may have a concave portion that engages with a convex portion provided on the inner peripheral portion of the tip of the cover member body, and may be fitted inside the tip portion of the cover member body. .
 この構成により、組立工程において、弾性部材をカバー部材本体に対して容易に組み付けることができる。 With this configuration, the elastic member can be easily assembled to the cover member main body in the assembly process.
 上記の注射器において、前記弾性部材は、前記カバー部材本体の先端部に設けられた溝部に嵌合し、前記先端部の外周面から突出していてもよい。 In the above-described syringe, the elastic member may be fitted into a groove provided at a distal end portion of the cover member main body and protrude from an outer peripheral surface of the distal end portion.
 この構成により、弾性部材の材料使用量を抑制できるともに、組立工程において、弾性部材をカバー部材本体に対して容易に組み付けることができる。 With this configuration, the amount of material used for the elastic member can be suppressed, and the elastic member can be easily assembled to the cover member main body in the assembly process.
 上記の注射器において、前記バレル内に摺動可能に挿入されたガスケットと、前記ガスケットに連結され又は前記ガスケットに連結可能な押し子と、前記バレルと前記ガスケットとにより形成される液室に充填された薬液と、を備えてもよい。 In the above syringe, a liquid chamber formed by the gasket and the gasket that is slidably inserted into the barrel, a pusher that is connected to or connectable to the gasket, and the barrel and the gasket is filled. And a chemical solution.
 本発明の注射器によれば、皮膚に対して斜めに穿刺針を穿刺するときに、カバー部材が皮膚に対して滑ることを抑制することができる。 According to the syringe of the present invention, when the puncture needle is punctured obliquely with respect to the skin, the cover member can be prevented from sliding with respect to the skin.
第1実施形態に係る注射器の全体斜視図である。It is the whole syringe perspective view concerning a 1st embodiment. 第1実施形態に係る注射器の先端部の断面図である。It is sectional drawing of the front-end | tip part of the syringe which concerns on 1st Embodiment. 第1実施形態に係る注射器の作用を説明する第1の図である。It is the 1st figure explaining an operation of the syringe concerning a 1st embodiment. 第1実施形態に係る注射器の作用を説明する第2の図である。It is a 2nd figure explaining the effect | action of the syringe which concerns on 1st Embodiment. 第2実施形態に係る注射器の先端部の断面図である。It is sectional drawing of the front-end | tip part of the syringe which concerns on 2nd Embodiment. 第3実施形態に係る注射器の先端部の断面図である。It is sectional drawing of the front-end | tip part of the syringe which concerns on 3rd Embodiment. 第4実施形態に係る注射器の先端部の断面図である。It is sectional drawing of the front-end | tip part of the syringe which concerns on 4th Embodiment. 第5実施形態に係る注射器の先端部の断面図である。It is sectional drawing of the front-end | tip part of the syringe which concerns on 5th Embodiment. 第6実施形態に係る注射器の先端部の断面図である。It is sectional drawing of the front-end | tip part of the syringe which concerns on 6th Embodiment.
 以下、本発明に係る注射器について好適な複数の実施形態を挙げ、添付の図面を参照しながら説明する。なお、以下の説明における「ユーザ」は、患者に対して薬液(注射液)を投与する者を指すが、該ユーザは医師や看護師等に限定されるものではなく、患者自身も含まれる。以下の説明における「基端」は、注射器を操作するユーザに近接する側の端部を指し、「先端」は、ユーザから離間する側の端部を指す。第2~第6実施形態において、第1実施形態と同一又は同様な要素には同一の参照符号を付し、詳細な説明を省略する。 Hereinafter, preferred embodiments of the syringe according to the present invention will be described with reference to the accompanying drawings. Note that “user” in the following description refers to a person who administers a medical solution (injection solution) to a patient, but the user is not limited to a doctor, a nurse, or the like, and includes the patient itself. In the following description, “proximal end” refers to an end portion on the side close to the user who operates the syringe, and “tip” refers to an end portion on the side away from the user. In the second to sixth embodiments, the same or similar elements as those in the first embodiment are denoted by the same reference numerals, and detailed description thereof is omitted.
[第1実施形態]
 図1において、本実施形態に係る注射器10Aは、製品提供状態で薬液Mが予め充填されたプレフィルドシリンジとして構成されている。注射器10Aは、中空状のバレル12と、バレル12内に充填された薬液Mと、バレル12の先端部から先端方向に突出した穿刺針14と、バレル12内に挿入されたガスケット16と、ガスケット16に連結された押し子18と、バレル12に取り付けられた保護装置20とを備える。
[First Embodiment]
In FIG. 1, the syringe 10A according to the present embodiment is configured as a prefilled syringe that is pre-filled with a chemical M in a product provision state. The syringe 10A includes a hollow barrel 12, a drug solution M filled in the barrel 12, a puncture needle 14 protruding from the distal end portion of the barrel 12 in the distal direction, a gasket 16 inserted into the barrel 12, and a gasket. 16 includes a pusher 18 connected to 16 and a protection device 20 attached to the barrel 12.
 バレル12は、略円筒形状のバレル胴部22を有するとともに基端に基端開口部を有する中空体である。バレル胴部22の基端外周部には、フランジ24が径方向外方に向かって突出形成されている。バレル胴部22の先端部には針保持部26が設けられている。針保持部26は、バレル胴部22に対して縮径して先端方向に延出し、穿刺針14の基端部を保持している。フランジ24及び針保持部26は、バレル胴部22に一体的に形成されている。 The barrel 12 is a hollow body having a substantially cylindrical barrel body 22 and a proximal end opening at the proximal end. A flange 24 is formed on the outer peripheral portion of the base end of the barrel body 22 so as to protrude outward in the radial direction. A needle holder 26 is provided at the tip of the barrel body 22. The needle holding part 26 is reduced in diameter with respect to the barrel body part 22 and extends in the distal direction, and holds the proximal end part of the puncture needle 14. The flange 24 and the needle holding part 26 are formed integrally with the barrel body part 22.
 バレル12内には、基端開口部を介してガスケット16が挿入されている。ガスケット16によってバレル12の基端側が液密に封止され、薬液Mがバレル12内に封入されている。ガスケット16は、その外周部がバレル12の内周面に液密に接するとともに、バレル12内に摺動可能に配置されている。 In the barrel 12, a gasket 16 is inserted through a base end opening. The proximal end side of the barrel 12 is liquid-tightly sealed by the gasket 16, and the chemical solution M is sealed in the barrel 12. The gasket 16 is arranged so that its outer peripheral portion is in liquid-tight contact with the inner peripheral surface of the barrel 12 and is slidable in the barrel 12.
 ガスケット16には、押し子18の先端部が連結されている。ユーザが押し子18を押圧することにより、ガスケット16がバレル12内を先端方向に摺動する。なお、押し子18は、穿刺針14を患者に穿刺し、薬液Mを患者に投与するときにガスケット16に連結されてもよい。 The tip of a pusher 18 is connected to the gasket 16. When the user presses the pusher 18, the gasket 16 slides in the barrel 12 in the distal direction. The pusher 18 may be connected to the gasket 16 when the patient is punctured with the puncture needle 14 and the medicinal solution M is administered to the patient.
 穿刺針14は、流体通路であるルーメンが形成された中空体であり、その先端には鋭利な針先15が形成されている。穿刺針14は、針保持部26から先端方向に突出している。穿刺針14のルーメンは、穿刺針14の基端開口を介してバレル12の中空部(液室)と連通している。 The puncture needle 14 is a hollow body in which a lumen as a fluid passage is formed, and a sharp needle tip 15 is formed at the tip thereof. The puncture needle 14 protrudes from the needle holding portion 26 in the distal direction. The lumen of the puncture needle 14 communicates with the hollow portion (liquid chamber) of the barrel 12 through the proximal end opening of the puncture needle 14.
 穿刺針14は、針保持部26の中心部に固着・保持されている。バレル12の中空内部に収容された薬液Mは、穿刺針14のルーメンの先端から吐出されて患者に投与される。 The puncture needle 14 is fixed and held at the center of the needle holding part 26. The drug solution M accommodated in the hollow interior of the barrel 12 is discharged from the distal end of the lumen of the puncture needle 14 and administered to the patient.
 保護装置20は、患者への穿刺針14の穿刺を行う前、及び行った後に穿刺針14を覆うことで、患者への薬液Mの投与時以外の不用意な穿刺を防止するためのものである。保護装置20は、少なくとも、バレル12に対して軸方向に相対変位可能な中空筒状のカバー部材28を備える。 The protection device 20 covers the puncture needle 14 before and after the puncture of the puncture needle 14 to the patient, thereby preventing inadvertent punctures other than when the drug solution M is administered to the patient. is there. The protection device 20 includes at least a hollow cylindrical cover member 28 that can be displaced relative to the barrel 12 in the axial direction.
 カバー部材28は、図1に示す使用前の初期状態で、先端が穿刺針14の針先15よりも先端側に位置しており、針先15を覆っている。カバー部材28は、穿刺対象である患者への穿刺針14の穿刺時にバレル12に対して基端方向に相対変位してカバー部材28の先端開口29から穿刺針14を先端方向に突出させる(図4参照)。カバー部材28は、穿刺後にはバレル12に対して先端方向に相対変位して穿刺針14の針先15を再び覆う。なお、初期状態で、穿刺針14の針先15はカバー部材28の先端開口29から先端方向に突出していてもよい。 In the initial state before use shown in FIG. 1, the cover member 28 has a distal end located closer to the distal end than the needle tip 15 of the puncture needle 14 and covers the needle tip 15. The cover member 28 is relatively displaced in the proximal direction with respect to the barrel 12 when the puncture needle 14 is punctured to the patient to be punctured, and the puncture needle 14 protrudes in the distal direction from the distal opening 29 of the cover member 28 (FIG. 4). The cover member 28 is displaced relative to the barrel 12 in the distal direction after puncturing, and covers the needle tip 15 of the puncture needle 14 again. In the initial state, the needle tip 15 of the puncture needle 14 may protrude from the distal end opening 29 of the cover member 28 in the distal direction.
 カバー部材28の構成材料は特に限定されないが、例えば、ポリプロピレン、ポリカーボネート、ポリアミド、ポリサルホン、ポリアリレート、ABS、高密度ポリエチレン等の樹脂材料が挙げられる。 The constituent material of the cover member 28 is not particularly limited, and examples thereof include resin materials such as polypropylene, polycarbonate, polyamide, polysulfone, polyarylate, ABS, and high-density polyethylene.
 このように作用するカバー部材28を備えた保護装置20の構成は、特定の構成に限られず、種々の形態を採り得る。従って、保護装置20は、例えば、以下に説明するように構成されてもよく、あるいは、他の形態に構成されてもよい。 The configuration of the protection device 20 provided with the cover member 28 acting in this way is not limited to a specific configuration, and can take various forms. Therefore, the protection device 20 may be configured as described below, for example, or may be configured in another form.
 保護装置20は、針保持部26の外周に回転可能に装着された内側部材と、内側部材に対して相対的に軸方向に移動可能なカバー部材28と、カバー部材28を先端方向に付勢するバネ部材(付勢部材)とを備えてよい。この場合、内側部材の外周部には径方向外方に突出したカム突起が形成される。カバー部材28は、先端から基端にかけて延在する貫通孔を形成する側壁を有する中空体からなり、貫通孔内に内側部材が収容される。カバー部材28の側壁には案内路が形成され、案内路内に内側部材のカム突起が移動可能に配置される。バネ部材は、カバー部材28の貫通孔内に収容されており、内側部材に対してカバー部材28を先端方向に付勢する。 The protection device 20 includes an inner member rotatably attached to the outer periphery of the needle holding portion 26, a cover member 28 that is movable in the axial direction relative to the inner member, and biases the cover member 28 in the distal direction. A spring member (biasing member). In this case, a cam protrusion protruding radially outward is formed on the outer peripheral portion of the inner member. The cover member 28 is formed of a hollow body having a side wall that forms a through hole extending from the front end to the base end, and the inner member is accommodated in the through hole. A guide path is formed on the side wall of the cover member 28, and the cam projection of the inner member is movably disposed in the guide path. The spring member is accommodated in the through hole of the cover member 28, and biases the cover member 28 in the distal direction with respect to the inner member.
 この場合、上記案内路は、カバー部材28が、患者への穿刺針14の穿刺操作に伴って初期位置からバレル12に対して基端方向に相対変位して後退位置へと案内され、穿刺針14の抜去操作に伴って後退位置からバレル12に対して先端方向に相対変位してロック位置へと案内されるように構成されてよい。この場合、カバー部材28は、初期位置で穿刺針14の針先15を覆う。後退位置で穿刺針14を先端開口29から突出させ、ロック位置で穿刺針14の針先15を覆う。なお、カバー部材28が初期位置から後退位置へと移動する際、バネ部材は軸方向に圧縮される。カバー部材28は、穿刺針14の抜去時にバネ部材の弾性付勢力によって後退位置からロック位置へと移動させられる。なお、カバー部材28が初期位置に位置しているとき、針先15はカバー部材28の先端開口29から露出(突出)していてもよい。 In this case, in the guide path, the cover member 28 is relatively displaced in the proximal direction with respect to the barrel 12 from the initial position with the puncture operation of the puncture needle 14 to the patient, and is guided to the retracted position. 14 may be configured to be relatively displaced in the distal direction with respect to the barrel 12 from the retracted position in accordance with the extraction operation 14 and guided to the lock position. In this case, the cover member 28 covers the needle tip 15 of the puncture needle 14 at the initial position. The puncture needle 14 is protruded from the distal end opening 29 at the retracted position, and the needle tip 15 of the puncture needle 14 is covered at the locked position. When the cover member 28 moves from the initial position to the retracted position, the spring member is compressed in the axial direction. The cover member 28 is moved from the retracted position to the locked position by the elastic biasing force of the spring member when the puncture needle 14 is removed. When the cover member 28 is located at the initial position, the needle tip 15 may be exposed (protruded) from the tip opening 29 of the cover member 28.
 また、この場合、カバー部材28が初期位置から後退位置を経由してロック位置まで移動する間に、内側部材は、カム突起が案内路内を移動することにより、カバー部材28に対して相対的に回転する。また、内側部材は、カバー部材28がロック位置に移動したとき、カバー部材28の内側部材に対する基端方向への相対変位を規制する。 In this case, while the cover member 28 moves from the initial position to the locked position via the retracted position, the inner member moves relative to the cover member 28 by the cam protrusion moving in the guide path. Rotate to. The inner member restricts relative displacement of the cover member 28 in the proximal direction with respect to the inner member when the cover member 28 moves to the lock position.
 注射器10Aの使用前においては、エラストマー等の柔軟な樹脂材料により構成された図示しないキャップが穿刺針14を覆っている。キャップは、針先15(穿刺針14の先端開口)を封止するように穿刺針14を覆って、カバー部材28内に挿入されている。注射器10Aの使用時には、キャップは、ユーザにより先端部が摘まれて先端方向に引き抜かれることで取り外される。 Before use of the syringe 10A, a cap (not shown) made of a flexible resin material such as an elastomer covers the puncture needle 14. The cap is inserted into the cover member 28 so as to cover the puncture needle 14 so as to seal the needle tip 15 (the distal end opening of the puncture needle 14). When the syringe 10A is used, the cap is removed by the user pulling the tip and pulling it in the direction of the tip.
 図2に示すように、カバー部材28の先端部には、カバー部材28が穿刺対象である患者の皮膚S(図3参照)に対して斜めに当接したときに皮膚Sに対する滑りを抑制する滑り抑制部30が設けられている。滑り抑制部30は、周方向に延在している。 As shown in FIG. 2, slipping of the cover member 28 against the skin S is suppressed when the cover member 28 obliquely contacts the patient's skin S (see FIG. 3) to be punctured. A slip suppression unit 30 is provided. The slip suppression unit 30 extends in the circumferential direction.
 本実施形態において、滑り抑制部30は、カバー部材28から突出した突起構造32からなる。突起構造32は、カバー部材28の外周面から径方向外側に突出するとともにカバー部材28の周方向に一周する円環状に形成されている。突起構造32は、カバー部材28に一体的に形成されている。突起構造32は、カバー部材28の軸方向に略垂直な先端面33を有する。なお、突起構造32の先端部は、基端方向に向かうに従って外径が増大するテーパ外面であってもよい。あるいは、突起構造32の先端部には、基端方向に凹むV字状の溝が設けられてもよい。 In the present embodiment, the slip suppression unit 30 includes a protruding structure 32 protruding from the cover member 28. The protruding structure 32 is formed in an annular shape that protrudes radially outward from the outer peripheral surface of the cover member 28 and makes a round in the circumferential direction of the cover member 28. The protruding structure 32 is formed integrally with the cover member 28. The protruding structure 32 has a tip surface 33 that is substantially perpendicular to the axial direction of the cover member 28. In addition, the front-end | tip part of the protrusion structure 32 may be a taper outer surface where an outer diameter increases as it goes to a base end direction. Alternatively, a V-shaped groove that is recessed in the proximal direction may be provided at the distal end portion of the protruding structure 32.
 カバー部材28は、突起構造32よりも先端側に、先端方向に向かう従って外径が減少する湾曲面35を持つ先端環状当接部34を有する。先端環状当接部34は、先端開口29を囲むとともに、突起構造32に対して先端方向に突出するように形成されている。突起構造32の外径は、先端環状当接部34の最大外径よりも大きい。先端環状当接部34からの突起構造32の径方向の突出高さは、例えば、0.3~5mmであり、好ましくは、0.5~2mmである。突起構造32の上記突出高さは、先端環状当接部34の外径と突起構造32の外径との差の2分の1である。 The cover member 28 has a tip annular contact portion 34 having a curved surface 35 whose outer diameter decreases toward the tip direction on the tip side of the protrusion structure 32. The tip annular contact portion 34 surrounds the tip opening 29 and is formed so as to protrude in the tip direction with respect to the protruding structure 32. The outer diameter of the protrusion structure 32 is larger than the maximum outer diameter of the tip annular contact portion 34. The protruding height in the radial direction of the protrusion structure 32 from the tip annular contact portion 34 is, for example, 0.3 to 5 mm, and preferably 0.5 to 2 mm. The protrusion height of the protrusion structure 32 is one half of the difference between the outer diameter of the tip annular contact portion 34 and the outer diameter of the protrusion structure 32.
 次に、上記のように構成された注射器10Aの作用及び効果を説明する。 Next, the operation and effect of the syringe 10A configured as described above will be described.
 患者に対して薬液Mを投与するときには、ユーザ(患者本人であってもよい)は、まず、ガスケット16に対して押し子18を連結し、図1に示す状態とする。なお、注射器10Aは、図1に示すように、押し子18が予めガスケット16に連結された状態で、ユーザに提供されてもよい。 When administering the drug solution M to the patient, the user (which may be the patient himself) first connects the pusher 18 to the gasket 16 to obtain the state shown in FIG. As shown in FIG. 1, the syringe 10 </ b> A may be provided to the user in a state where the pusher 18 is connected to the gasket 16 in advance.
 次に、ユーザは、キャップ(不図示)を把持して引っ張ることにより、カバー部材28からキャップを引き抜く。この時点では、上述したバネ部材の弾性付勢力によってカバー部材28が初期位置(穿刺前位置)に付勢されており、穿刺針14が先端の針先15までカバー部材28に囲繞された状態が保たれている。このため、穿刺針14がユーザ等に不用意に穿刺されることが防止される。 Next, the user pulls out the cap from the cover member 28 by grasping and pulling the cap (not shown). At this time, the cover member 28 is biased to the initial position (pre-puncture position) by the elastic biasing force of the spring member described above, and the puncture needle 14 is surrounded by the cover member 28 up to the tip 15 of the tip. It is kept. This prevents the puncture needle 14 from being punctured carelessly by a user or the like.
 次に、ユーザは、患者の穿刺箇所(腕等の皮膚S)にカバー部材28の先端部を押し付けて、カバー部材28の先端部を位置決めする。ユーザは、好みや状況等に応じて穿刺針14を皮膚Sに対して斜めに穿刺したい場合がある。この場合、図3のように、カバー部材28は、その軸方向が皮膚Sに対して斜めになる状態で皮膚Sと当接する。すなわち、カバー部材28は、円環状の先端面が皮膚Sに当接するのではなく、先端部の周方向の一部のみが皮膚Sに当接する。 Next, the user presses the distal end portion of the cover member 28 against the patient's puncture site (skin S such as an arm) to position the distal end portion of the cover member 28. The user may want to puncture the puncture needle 14 obliquely with respect to the skin S according to the preference or situation. In this case, as shown in FIG. 3, the cover member 28 comes into contact with the skin S in a state where the axial direction is oblique with respect to the skin S. That is, in the cover member 28, the annular tip surface does not contact the skin S, but only a part of the tip portion in the circumferential direction contacts the skin S.
 この場合、カバー部材28の先端部に設けられた突起構造32が皮膚Sに食い込んでいるため、カバー部材28が皮膚Sに対して滑ることが抑制される。従って、カバー部材28を位置決めした位置に容易に保持することができる。 In this case, since the protruding structure 32 provided at the tip of the cover member 28 bites into the skin S, the cover member 28 is prevented from sliding with respect to the skin S. Therefore, the cover member 28 can be easily held at the positioned position.
 次に、カバー部材28の先端部を皮膚Sに押し付けた状態で、ユーザがバレル12を先端方向に押し込むと、カバー部材28は、バネ部材の弾性付勢力に抗して、バレル12に対して基端方向に相対変位する。このような相対変位に伴い、図4のように、穿刺針14は、カバー部材28の先端開口29から露出されるとともに、患者に穿刺された状態となる。 Next, when the user pushes the barrel 12 in the distal direction with the distal end portion of the cover member 28 pressed against the skin S, the cover member 28 resists the elastic biasing force of the spring member against the barrel 12. Relative displacement in the proximal direction. With such relative displacement, as shown in FIG. 4, the puncture needle 14 is exposed from the distal end opening 29 of the cover member 28 and is punctured by the patient.
 この場合においても、カバー部材28の先端部に設けられた突起構造32が皮膚Sに食い込むため、カバー部材28が皮膚Sに対して滑ることが抑制される。従って、穿刺箇所において穿刺針14の軸方向と垂直な方向に余計な力がかかることがない。よって、穿刺時において患者に与える痛みや違和感が増大することを防止すことができる。 Also in this case, since the protruding structure 32 provided at the tip of the cover member 28 bites into the skin S, the cover member 28 is prevented from sliding with respect to the skin S. Therefore, no extra force is applied in the direction perpendicular to the axial direction of the puncture needle 14 at the puncture site. Therefore, it is possible to prevent the pain and discomfort given to the patient during puncturing from increasing.
 次に、ユーザは、穿刺針14が患者に穿刺された状態で、図1に示す押し子18を先端方向に押圧する。これによりバレル12内に充填されている薬液Mが穿刺針14のルーメンを経由して穿刺針14から吐出される。その結果、患者に対する薬液Mの投与がなされる。 Next, the user presses the pusher 18 shown in FIG. 1 in the distal direction with the puncture needle 14 being punctured by the patient. Thereby, the drug solution M filled in the barrel 12 is discharged from the puncture needle 14 via the lumen of the puncture needle 14. As a result, the drug solution M is administered to the patient.
 薬液Mの投与後、穿刺針14を患者から抜去するためにユーザが注射器10Aごとカバー部材28を患者から引き離すと、カバー部材28は、バネ部材の弾性付勢力によってバレル12に対して先端方向に相対変位して、穿刺針14の針先15を覆う。これにより、患者への薬液Mの投与後においても、不用意な穿刺を回避することができる。 When the user pulls the cover member 28 together with the syringe 10A from the patient to remove the puncture needle 14 from the patient after the administration of the medicinal solution M, the cover member 28 is moved in the distal direction with respect to the barrel 12 by the elastic biasing force of the spring member. The needle tip 15 of the puncture needle 14 is covered with relative displacement. Thereby, inadvertent puncture can be avoided even after administration of the drug solution M to the patient.
 以上説明したように、本実施形態に係る注射器10Aによれば、カバー部材28の先端部に滑り抑制部30が設けられているため、穿刺対象に対してカバー部材28を斜めに当接させた場合でも、カバー部材28が穿刺対象に対して滑ることを効果的に抑制することができる。従って、狙った部位に正確に穿刺針14を穿刺することができる。 As described above, according to the syringe 10A according to the present embodiment, since the slip suppression portion 30 is provided at the distal end portion of the cover member 28, the cover member 28 is brought into contact with the puncture target obliquely. Even in this case, the sliding of the cover member 28 with respect to the puncture target can be effectively suppressed. Therefore, the puncture needle 14 can be punctured accurately at the target site.
 また、本実施形態では、滑り抑制部30は、環状に形成されているため、穿刺対象に対するカバー部材28の周方向位置に関わらず、滑り抑制効果を発揮することができる。 Further, in the present embodiment, since the slip suppression portion 30 is formed in an annular shape, it is possible to exert a slip suppression effect regardless of the circumferential position of the cover member 28 with respect to the puncture target.
 しかも、本実施形態では、滑り抑制部30は、カバー部材28から突出した突起構造32を有するため、穿刺対象との接触時に突起構造32が穿刺対象に食い込むことにより、簡易構成で滑り抑制機能が得られる。 In addition, in the present embodiment, since the slip suppression unit 30 has the protrusion structure 32 protruding from the cover member 28, the protrusion structure 32 bites into the puncture target at the time of contact with the puncture target, thereby providing a slip suppression function with a simple configuration. can get.
 特に、突起構造32は、カバー部材28の外周面から突出しているため、滑り抑制機能を一層効果的に発揮することができる。 In particular, since the protrusion structure 32 protrudes from the outer peripheral surface of the cover member 28, the slip suppression function can be more effectively exhibited.
 本実施形態では、カバー部材28は、突起構造32よりも先端側に、先端方向に向かう従って外径が減少する湾曲面を有するため、穿刺対象に対する接触時の刺激を抑制しつつ滑りを抑制することができる。これにより、穿刺時において患者に与える痛みや違和感が増大することを防止することができる。 In the present embodiment, the cover member 28 has a curved surface whose outer diameter decreases in the distal direction from the protrusion structure 32, so that the slippage is suppressed while suppressing stimulation at the time of contact with the puncture target. be able to. Thereby, it is possible to prevent the pain and discomfort given to the patient during puncturing from increasing.
[第2実施形態]
 図5に示す第2実施形態に係る注射器10Bにおいて、カバー部材28の先端部には、カバー部材28が穿刺対象に対して斜めに当接したときに穿刺対象に対する滑りを抑制する滑り抑制部30として、突起構造40が一体的に設けられている。突起構造40は、カバー部材28の外周面から径方向外側に突出するとともにカバー部材28の周方向に一周する円環状に形成されている。
[Second Embodiment]
In the syringe 10B according to the second embodiment shown in FIG. 5, the slip suppression unit 30 that suppresses slipping with respect to the puncture target when the cover member 28 obliquely contacts the puncture target at the distal end portion of the cover member 28. The protrusion structure 40 is integrally provided. The protruding structure 40 is formed in an annular shape that protrudes radially outward from the outer peripheral surface of the cover member 28 and makes a round in the circumferential direction of the cover member 28.
 突起構造40は、軸方向に並ぶ複数(図示例では、3つ)の突起を有する。具体的に、突起構造40は、環状の第1突起42と、第1突起42よりも基端側に設けられた環状の第2突起44と、第2突起44よりも基端側に設けられた環状の第3突起46とを有する。 The protrusion structure 40 has a plurality (three in the illustrated example) of protrusions arranged in the axial direction. Specifically, the protrusion structure 40 is provided on the proximal end side of the annular first protrusion 42, the annular second protrusion 44 provided on the proximal end side with respect to the first protrusion 42, and the second protrusion 44. And an annular third protrusion 46.
 複数の突起において隣り合う突起は、先端側の突起よりも基端側の突起の方が径方向外側に突出している。従って、注射器10Bでは、第2突起44の外径は、第1突起42の外径よりも大きい。第3突起46の外径は、第2突起44の外径よりも大きい。 The adjacent protrusions of the plurality of protrusions are such that the proximal protrusion protrudes radially outward than the distal protrusion. Therefore, in the syringe 10 </ b> B, the outer diameter of the second protrusion 44 is larger than the outer diameter of the first protrusion 42. The outer diameter of the third protrusion 46 is larger than the outer diameter of the second protrusion 44.
 第1突起42、第2突起44及び第3突起46は、それぞれ、カバー部材28の軸方向に略垂直な先端面42a、44a、46aを有する。なお、第1突起42、第2突起44及び第3突起46の先端部は、それぞれ、基端方向に向かうに従って外径が増大するテーパ外面であってもよい。あるいは、第1突起42、第2突起44及び第3突起46の先端部には、それぞれ、基端方向に凹むV字状の溝が設けられてもよい。 The first protrusion 42, the second protrusion 44, and the third protrusion 46 have front end surfaces 42a, 44a, 46a substantially perpendicular to the axial direction of the cover member 28, respectively. In addition, the front-end | tip part of the 1st protrusion 42, the 2nd protrusion 44, and the 3rd protrusion 46 may each be a taper outer surface where an outer diameter increases as it goes to a base end direction. Alternatively, V-shaped grooves that are recessed in the proximal direction may be provided at the distal ends of the first protrusion 42, the second protrusion 44, and the third protrusion 46, respectively.
 注射器10Bのその他の部分の構成は、第1実施形態に係る注射器10Aと同様に構成されている。 The configuration of the other parts of the syringe 10B is the same as that of the syringe 10A according to the first embodiment.
 上記のように構成された突起構造40を備えた注射器10Bによっても、上述した第1実施形態に係る注射器10Aと同様に、穿刺対象である患者の皮膚Sに対してカバー部材28を斜めに当接させた際に、カバー部材28が皮膚Sに対して滑ることを効果的に抑制することができる。 Similarly to the syringe 10A according to the first embodiment described above, the syringe 10B including the protruding structure 40 configured as described above also applies the cover member 28 obliquely to the skin S of the patient to be punctured. The sliding of the cover member 28 with respect to the skin S when contacted can be effectively suppressed.
 また、この注射器10Bによれば、突起構造40は、軸方向に並ぶ複数の突起(第1突起42、第2突起44及び第3突起46)を有するため、一層良好な滑り抑制機能が得られる。さらに、複数の突起において隣り合う突起は、先端側の突起よりも基端側の突起の方が径方向外側に突出しているため、隣り合う突起における基端側の突起についても皮膚Sに食い込ませ、滑り抑制機能を確実に発揮することができる。 Moreover, according to this syringe 10B, since the protrusion structure 40 has a plurality of protrusions (first protrusion 42, second protrusion 44, and third protrusion 46) arranged in the axial direction, a better slip suppression function can be obtained. . Further, since the adjacent protrusions of the plurality of protrusions protrude outward in the radial direction from the protrusion on the distal end side, the protrusions on the proximal end side of the adjacent protrusions also bite into the skin S. In addition, the slip prevention function can be surely exhibited.
 なお、第2実施形態のうち、第1実施形態と共通する部分については、第1実施形態と同一又は同様の作用及び効果が得られる。 In addition, about the part which is common in 1st Embodiment among 2nd Embodiment, the same or similar operation | movement and effect as 1st Embodiment are acquired.
[第3実施形態]
 図6に示す第3実施形態に係る注射器10Cは、第1実施形態に係る注射器10Aにおいて、突起構造32に代えて、弾性材料(エラストマー)により構成された弾性部材52aが設けられたものである。すなわち、カバー部材28aの先端部には、カバー部材28aが穿刺対象である皮膚Sに対して斜めに当接したときに皮膚Sに対する滑りを抑制する滑り抑制部30として、弾性部材52aが設けられている。
[Third Embodiment]
The syringe 10C according to the third embodiment shown in FIG. 6 is provided with an elastic member 52a made of an elastic material (elastomer) instead of the protruding structure 32 in the syringe 10A according to the first embodiment. . That is, an elastic member 52a is provided at the distal end portion of the cover member 28a as the slip suppression portion 30 that suppresses slipping on the skin S when the cover member 28a obliquely contacts the skin S that is the puncture target. ing.
 具体的に、カバー部材28aは、カバー部材本体48と、カバー部材本体48の先端部に取り付けられた弾性部材52aとを有する。このカバー部材本体48は、第1実施形態におけるカバー部材28から突起構造32をなくしたものに相当する。 Specifically, the cover member 28 a includes a cover member main body 48 and an elastic member 52 a attached to the tip of the cover member main body 48. The cover member main body 48 corresponds to the cover member 28 in the first embodiment in which the protruding structure 32 is eliminated.
 弾性部材52aを構成する弾性材料としては、例えば、天然ゴム、ブチルゴム、イソプレンゴム、ブタジエンゴム、スチレン-ブタジエンゴム、シリコーンゴムのような各種ゴム材料や、ポリウレタン系、ポリエステル系、ポリアミド系、オレフィン系、スチレン系等の各種熱可塑性エラストマー、あるいはそれらの混合物等が挙げられる。 Examples of the elastic material constituting the elastic member 52a include various rubber materials such as natural rubber, butyl rubber, isoprene rubber, butadiene rubber, styrene-butadiene rubber, and silicone rubber, polyurethane, polyester, polyamide, and olefin. , Various thermoplastic elastomers such as styrene, or a mixture thereof.
 弾性部材52aは、カバー部材本体48の円形の先端面に沿って円環状に形成されている。弾性部材52aの基端面には凹部55が設けられている。カバー部材28aの先端面には先端方向に突出する突起57が設けられている。突起57が凹部55に嵌り込むことにより弾性部材52aがカバー部材本体48に固定されている。なお、凹部55及び突起57は、それぞれ環状に設けられていてもよく、あるいは周方向に間隔を置いて複数設けられていてもよい。弾性部材52aの孔部53は、カバー部材28aの先端開口29と連通している。図6において、孔部53の直径(弾性部材52aの内径)は、カバー部材本体48の先端開口29の直径よりも若干だけ大きい。孔部53の直径は、カバー部材28aの先端開口29の直径と同じか、先端開口29の直径より小さくてもよい。 The elastic member 52 a is formed in an annular shape along the circular front end surface of the cover member main body 48. A recess 55 is provided on the base end surface of the elastic member 52a. A protrusion 57 protruding in the distal direction is provided on the distal end surface of the cover member 28a. The elastic member 52 a is fixed to the cover member main body 48 by fitting the projection 57 into the concave portion 55. In addition, the recessed part 55 and the processus | protrusion 57 may each be provided cyclically | annularly, or multiple may be provided at intervals in the circumferential direction. The hole 53 of the elastic member 52a communicates with the tip opening 29 of the cover member 28a. In FIG. 6, the diameter of the hole 53 (the inner diameter of the elastic member 52 a) is slightly larger than the diameter of the tip opening 29 of the cover member main body 48. The diameter of the hole 53 may be the same as or smaller than the diameter of the tip opening 29 of the cover member 28 a.
 弾性部材52aと皮膚Sとの間の摩擦係数は、カバー部材本体48と皮膚Sとの間の摩擦係数よりも大きい。従って、弾性部材52aは、カバー部材本体48よりも皮膚Sに対して滑りにくい。 The friction coefficient between the elastic member 52a and the skin S is larger than the friction coefficient between the cover member main body 48 and the skin S. Therefore, the elastic member 52 a is less slidable with respect to the skin S than the cover member main body 48.
 注射器10Cのその他の部分の構成は、第1実施形態に係る注射器10Aと同様に構成されている。 The other parts of the syringe 10C are configured in the same manner as the syringe 10A according to the first embodiment.
 上記のように構成された弾性部材52aを備えた注射器10Cによれば、穿刺針14の針先15がカバー部材28aにより覆われた状態でカバー部材28aを皮膚Sに対して位置決めするために、カバー部材28aの先端部を皮膚Sに当接させると、注射器10Cの最先端部に設けられた弾性部材52aが皮膚Sに当接する。従って、カバー部材28aを皮膚Sに対して斜めに当接させた場合でも、弾性部材52aにより、カバー部材28aが皮膚Sに対して滑ることが抑制される。従って、カバー部材28aを位置決めしたい位置に容易に保持することができる。 According to the syringe 10C including the elastic member 52a configured as described above, in order to position the cover member 28a with respect to the skin S in a state where the needle tip 15 of the puncture needle 14 is covered with the cover member 28a, When the tip of the cover member 28a is brought into contact with the skin S, the elastic member 52a provided at the most distal end of the syringe 10C comes into contact with the skin S. Therefore, even when the cover member 28a is brought into contact with the skin S at an angle, the elastic member 52a prevents the cover member 28a from sliding on the skin S. Therefore, the cover member 28a can be easily held at a position where it is desired to position.
 このように、注射器10Cによっても、上述した第1実施形態に係る注射器10Aと同様に、穿刺対象である患者の皮膚Sに対してカバー部材28aを斜めに当接させた際に、カバー部材28aが皮膚Sに対して滑ることを効果的に抑制することができる。 As described above, when the cover member 28a is obliquely brought into contact with the skin S of the patient that is the puncture target, the cover member 28a is also provided by the syringe 10C, similarly to the syringe 10A according to the first embodiment described above. Can be effectively suppressed from slipping on the skin S.
 特に、この注射器10Cでは、滑り抑制部30は、弾性材料により構成された弾性部材52aであるため、皮膚Sに対する接触時の刺激を抑制しつつ良好な滑り抑制機能が得られる。また、弾性部材52aは、カバー部材本体48の先端面に固定されているため、カバー部材28aの先端部に弾性部材52aを簡単に設けることができる。 In particular, in this syringe 10C, the slip suppression unit 30 is an elastic member 52a made of an elastic material, so that a favorable slip suppression function can be obtained while suppressing irritation at the time of contact with the skin S. Further, since the elastic member 52a is fixed to the distal end surface of the cover member main body 48, the elastic member 52a can be easily provided at the distal end portion of the cover member 28a.
 なお、第3実施形態のうち、第1実施形態と共通する部分については、第1実施形態と同一又は同様の作用及び効果が得られる。 In addition, about the part which is common in 1st Embodiment among 3rd Embodiment, the same or similar operation | movement and effect as 1st Embodiment are acquired.
[第4実施形態]
 図7に示す第4実施形態に係る注射器10Dのカバー部材28aは、カバー部材本体48と、カバー部材本体48の先端部に固定された弾性材料からなる弾性部材52bとを有する。弾性部材52bは、カバー部材28aが穿刺対象である皮膚Sに対して斜めに当接したときに皮膚Sに対する滑りを抑制する滑り抑制部30として機能する。弾性部材52bは、第3実施形態における弾性部材52aと同様の材料により構成され得る。
[Fourth Embodiment]
The cover member 28a of the syringe 10D according to the fourth embodiment shown in FIG. 7 includes a cover member main body 48 and an elastic member 52b made of an elastic material fixed to the distal end portion of the cover member main body 48. The elastic member 52b functions as a slip suppression unit 30 that suppresses slipping on the skin S when the cover member 28a obliquely contacts the skin S that is the puncture target. The elastic member 52b can be made of the same material as the elastic member 52a in the third embodiment.
 弾性部材52bは、円環状に形成されている。弾性部材52bは、カバー部材本体48の先端部を外周面48aから先端面48bに亘って覆っている。弾性部材52bは、カバー部材28aの先端開口29と連通する孔部53を有する。弾性部材52bの内周面には、径方向内側に突出する係合突起56が設けられている。係合突起56は、周方向に延在する環状の突起である。係合突起56は、周方向に間隔を置いて設けられた複数の突起であってもよい。 The elastic member 52b is formed in an annular shape. The elastic member 52b covers the distal end portion of the cover member main body 48 from the outer peripheral surface 48a to the distal end surface 48b. The elastic member 52b has a hole 53 that communicates with the tip opening 29 of the cover member 28a. On the inner peripheral surface of the elastic member 52b, an engagement protrusion 56 that protrudes radially inward is provided. The engagement protrusion 56 is an annular protrusion that extends in the circumferential direction. The engaging protrusions 56 may be a plurality of protrusions provided at intervals in the circumferential direction.
 カバー部材本体48の先端部の外周面48aには、径方向内側に凹む係合溝58が設けられている。係合溝58は、周方向に延在する環状の溝である。係合突起56が複数の突起からなる場合、係合溝58は、周方向に間隔を置いて設けられた複数の溝であってもよい。係合突起56と係合溝58とが係合することにより、カバー部材本体48の先端部に弾性部材52bが固定されている。 The outer peripheral surface 48a of the front-end | tip part of the cover member main body 48 is provided with the engaging groove 58 dented to radial inside. The engagement groove 58 is an annular groove extending in the circumferential direction. When the engagement protrusion 56 includes a plurality of protrusions, the engagement groove 58 may be a plurality of grooves provided at intervals in the circumferential direction. The elastic member 52 b is fixed to the distal end portion of the cover member main body 48 by the engagement protrusion 56 and the engagement groove 58 engaging with each other.
 弾性部材52bは、カバー部材本体48の先端部の外周面48aを囲む周壁部60と、周壁部60の先端から径方向内側に湾曲するとともに孔部53を囲む先端湾曲部62とを有する。周壁部60の外径及び内径は、先端方向に向かって減少している。周壁部60の外径及び内径は、軸方向に一定であってもよい。周壁部60の内周面60aは、カバー部材本体48の先端部の外周面48aと接触している。先端湾曲部62の基端面62aは、カバー部材本体48の先端部の先端面48bと接触している。 The elastic member 52 b includes a peripheral wall portion 60 that surrounds the outer peripheral surface 48 a of the distal end portion of the cover member main body 48, and a distal end curved portion 62 that curves radially inward from the distal end of the peripheral wall portion 60 and surrounds the hole portion 53. The outer diameter and inner diameter of the peripheral wall portion 60 decrease toward the distal end direction. The outer diameter and inner diameter of the peripheral wall portion 60 may be constant in the axial direction. The inner peripheral surface 60 a of the peripheral wall portion 60 is in contact with the outer peripheral surface 48 a of the tip portion of the cover member main body 48. The proximal end surface 62 a of the distal end bending portion 62 is in contact with the distal end surface 48 b of the distal end portion of the cover member main body 48.
 注射器10Dのその他の部分の構成は、第1実施形態に係る注射器10Aと同様に構成されている。 The other parts of the syringe 10D are configured in the same manner as the syringe 10A according to the first embodiment.
 上記のように構成された弾性部材52bを備えた注射器10Dによっても、上述した注射器10A~10Cと同様に、穿刺対象である患者の皮膚Sに対してカバー部材28aを斜めに当接させた際に、カバー部材28aが穿刺対象に対して滑ることを効果的に抑制することができる。また、この注射器10Dでは、滑り抑制部30は、弾性材料により構成された弾性部材52bであるため、皮膚Sに対する接触時の刺激を抑制しつつ良好な滑り抑制機能が得られる。 Similarly to the above-described syringes 10A to 10C, the syringe 10D including the elastic member 52b configured as described above also has the cover member 28a obliquely brought into contact with the skin S of the patient to be punctured. In addition, it is possible to effectively prevent the cover member 28a from slipping on the puncture target. Moreover, in this syringe 10D, since the slip suppression part 30 is the elastic member 52b comprised with the elastic material, a favorable slip suppression function is obtained, suppressing the irritation | stimulation at the time of the contact with the skin S.
 特に、この注射器10Dでは、弾性部材52bは、カバー部材本体48の先端部を外周面48aから先端面48bに亘って覆っているため、穿刺対象に対する穿刺針14の穿刺角度に関わらず、穿刺対象に対する滑りを効果的に抑制することができる。 In particular, in this syringe 10D, the elastic member 52b covers the distal end portion of the cover member main body 48 from the outer peripheral surface 48a to the distal end surface 48b, and therefore the puncture target regardless of the puncture angle of the puncture needle 14 with respect to the puncture target. Can be effectively suppressed.
 なお、第4実施形態のうち、第1実施形態と共通する部分については、第1実施形態と同一又は同様の作用及び効果が得られる。 In addition, about the part which is common in 1st Embodiment among 4th Embodiment, the same or similar operation | movement and effect as 1st Embodiment are acquired.
[第5実施形態]
 図8に示す第5実施形態に係る注射器10Eのカバー部材28aは、カバー部材本体48と、カバー部材本体48の先端部に固定された弾性材料からなる弾性部材52cとを有する。弾性部材52cは、カバー部材28aが穿刺対象に対して斜めに当接したときに穿刺対象に対する滑りを抑制する滑り抑制部30として機能する。弾性部材52cは、第3実施形態における弾性部材52aと同様の材料により構成され得る。
[Fifth Embodiment]
The cover member 28a of the syringe 10E according to the fifth embodiment shown in FIG. 8 includes a cover member main body 48 and an elastic member 52c made of an elastic material fixed to the distal end portion of the cover member main body 48. The elastic member 52c functions as the slip suppression unit 30 that suppresses slipping on the puncture target when the cover member 28a is in contact with the puncture target at an angle. The elastic member 52c can be made of the same material as the elastic member 52a in the third embodiment.
 弾性部材52cは、円環状に形成されており、軸方向に貫通し且つカバー部材本体48の内腔と連通する孔部63を有する。穿刺針14は、孔部63を介してカバー部材28aの先端方向に突出可能である。弾性部材52cは、カバー部材本体48の先端内周部に設けられた凸部64と係合する凹部66を有し、カバー部材28aの先端部内側に嵌合している。 The elastic member 52 c is formed in an annular shape, and has a hole 63 that penetrates in the axial direction and communicates with the inner cavity of the cover member main body 48. The puncture needle 14 can project in the distal direction of the cover member 28a through the hole 63. The elastic member 52c has a concave portion 66 that engages with the convex portion 64 provided on the inner peripheral portion of the front end of the cover member main body 48, and is fitted inside the front end portion of the cover member 28a.
 凹部66は、弾性部材52cの外周面から径方向内側に凹み且つ周方向に一周延在する環状に形成されている。凸部64は、径方向内側に突出し且つ周方向に一周延在する環状に形成されている。凹部66と凸部64とが係合することにより、カバー部材本体48の先端部に弾性部材52cが固定されている。 The recess 66 is formed in an annular shape that is recessed inward in the radial direction from the outer peripheral surface of the elastic member 52c and extends once in the circumferential direction. The convex portion 64 is formed in an annular shape that protrudes inward in the radial direction and extends around the circumference in the circumferential direction. The elastic member 52 c is fixed to the distal end portion of the cover member main body 48 by engaging the concave portion 66 and the convex portion 64.
 上記のように構成された弾性部材52cを備えた注射器10Eによっても、上述した注射器10A~10Dと同様に、穿刺対象である患者の皮膚Sに対してカバー部材28aを斜めに当接させた際に、カバー部材28aが皮膚Sに対して滑ることを効果的に抑制することができる。また、この注射器10Eでは、滑り抑制部30は、弾性材料により構成された弾性部材52cであるため、皮膚Sに対する接触時の刺激を抑制しつつ良好な滑り抑制機能が得られる。 Similarly to the above-described syringes 10A to 10D, the syringe 10E provided with the elastic member 52c configured as described above also causes the cover member 28a to be in contact with the skin S of the patient to be punctured obliquely. In addition, the sliding of the cover member 28a with respect to the skin S can be effectively suppressed. Moreover, in this syringe 10E, since the slip suppression part 30 is the elastic member 52c comprised with the elastic material, a favorable slip suppression function is obtained, suppressing the irritation | stimulation at the time of the contact with the skin S.
 特に、この注射器10Eでは、弾性部材52cは、カバー部材本体48の先端内周部に設けられた凸部64と係合する凹部66を有し、カバー部材本体48の先端部内側に嵌合しているため、組立工程において、弾性部材52cをカバー部材本体48に対して容易に組み付けることができる。 In particular, in the syringe 10E, the elastic member 52c has a concave portion 66 that engages with the convex portion 64 provided on the inner peripheral portion of the front end of the cover member main body 48, and fits inside the front end portion of the cover member main body 48. Therefore, the elastic member 52c can be easily assembled to the cover member main body 48 in the assembly process.
 なお、第5実施形態のうち、第1実施形態と共通する部分については、第1実施形態と同一又は同様の作用及び効果が得られる。 In addition, about the part which is common in 1st Embodiment among 5th Embodiment, the same or similar operation | movement and effect as 1st Embodiment are acquired.
[第6実施形態]
 図9に示す第6実施形態に係る注射器10Fのカバー部材28aは、カバー部材本体48と、カバー部材本体48の先端部に固定された弾性材料からなる弾性部材52dとを有する。弾性部材52dは、カバー部材28aが穿刺対象である皮膚Sに対して斜めに当接したときに皮膚Sに対する滑りを抑制する滑り抑制部30として機能する。弾性部材52dは、第3実施形態における弾性部材52aと同様の材料により構成され得る。
[Sixth Embodiment]
The cover member 28a of the syringe 10F according to the sixth embodiment shown in FIG. 9 includes a cover member main body 48 and an elastic member 52d made of an elastic material fixed to the distal end portion of the cover member main body 48. The elastic member 52d functions as the slip suppression unit 30 that suppresses slipping on the skin S when the cover member 28a is in contact with the skin S that is a puncture target obliquely. The elastic member 52d can be made of the same material as the elastic member 52a in the third embodiment.
 弾性部材52dはカバー部材本体48の先端部を囲む円環状に形成されている。弾性部材52dは、カバー部材本体48の先端部に設けられた溝部68に嵌合している。弾性部材52dの内周部が溝部68に嵌合することにより、カバー部材本体48の先端部に弾性部材52dが固定されている。弾性部材52dは、カバー部材本体48の先端部の外周面48aから径方向外側に突出している。溝部68は、カバー部材本体48の先端部の外周面48aから径方向内側に凹み且つ周方向に一周延在する環状に形成されている。 The elastic member 52d is formed in an annular shape surrounding the tip of the cover member main body 48. The elastic member 52 d is fitted in a groove 68 provided at the tip of the cover member main body 48. The elastic member 52d is fixed to the tip of the cover member main body 48 by fitting the inner peripheral portion of the elastic member 52d into the groove 68. The elastic member 52d protrudes radially outward from the outer peripheral surface 48a of the front end portion of the cover member main body 48. The groove portion 68 is formed in an annular shape that is recessed radially inward from the outer peripheral surface 48a of the distal end portion of the cover member main body 48 and extends one round in the circumferential direction.
 上記のように構成された注射器10Fによっても、上述した注射器10A~10Eと同様に、穿刺対象である患者の皮膚Sに対してカバー部材28aを斜めに当接させた際に、カバー部材28aが穿刺対象に対して滑ることを効果的に抑制することができる。また、この注射器10Fでは、滑り抑制部30は、弾性材料により構成された弾性部材52dであるため、皮膚Sに対する接触時の刺激を抑制しつつ良好な滑り抑制機能が得られる。 Also with the syringe 10F configured as described above, when the cover member 28a is obliquely brought into contact with the skin S of the patient to be punctured, as in the syringes 10A to 10E described above, the cover member 28a is It is possible to effectively suppress sliding with respect to the puncture target. Moreover, in this syringe 10F, since the slip suppression part 30 is the elastic member 52d comprised with the elastic material, a favorable slip suppression function is obtained, suppressing the irritation | stimulation at the time of the contact with the skin S.
 特に、この注射器10Fでは、弾性部材52dは、カバー部材本体48の先端部に設けられた溝部68に嵌合し、カバー部材本体48の先端部の外周面48aから突出しているため、弾性部材52aの材料使用量を抑制することができる。また、組立工程において、弾性部材52dをカバー部材本体48に対して容易に組み付けることができる。 In particular, in this syringe 10F, the elastic member 52d is fitted into the groove 68 provided at the distal end portion of the cover member main body 48 and protrudes from the outer peripheral surface 48a of the distal end portion of the cover member main body 48. The amount of material used can be suppressed. In the assembly process, the elastic member 52d can be easily assembled to the cover member main body 48.
 なお、第6実施形態のうち、第1実施形態と共通する部分については、第1実施形態と同一又は同様の作用及び効果が得られる。 In addition, about the part which is common in 1st Embodiment among 6th Embodiment, the same operation | movement and effect as 1st Embodiment are obtained.
 上述した注射器10C~10Fにおいて、弾性部材52a~52dの外周部に突起構造32(図2)又は突起構造40(図5)が一体的に設けられてもよい。この場合、突起構造32、40は弾性材料からなる。 In the above-described syringes 10C to 10F, the protrusion structure 32 (FIG. 2) or the protrusion structure 40 (FIG. 5) may be integrally provided on the outer periphery of the elastic members 52a to 52d. In this case, the protruding structures 32 and 40 are made of an elastic material.
 本発明は上記実施形態に限定されるものではなく、本発明の要旨を逸脱しない範囲において、種々の改変が可能である。 The present invention is not limited to the above embodiment, and various modifications can be made without departing from the scope of the present invention.

Claims (14)

  1.  バレル(12)と、
     前記バレル(12)の先端部から先端方向に突出し、先端に針先(15)を有する穿刺針(14)と、
     前記バレル(12)に対して軸方向に相対変位可能な中空筒状のカバー部材(28、28a)を有し、初期状態で前記カバー部材(28、28a)が前記穿刺針(14)の少なくとも一部を覆い、穿刺対象への前記穿刺針(14)の穿刺時に前記穿刺対象に対して押しつけられることで前記カバー部材(28、28a)が前記バレル(12)に対して基端方向に相対変位し、前記穿刺対象への前記穿刺針(14)の穿刺後に前記カバー部材(28、28a)により前記針先(15)を覆うように構成された保護装置(20)と、を備え、
     前記カバー部材(28、28a)の先端部には、周方向に延在し、前記カバー部材(28、28a)が前記穿刺対象に対して斜めに当接したときに前記穿刺対象に対する滑りを抑制する滑り抑制部(30)が設けられている、
     ことを特徴とする注射器(10A~10F)。
    Barrel (12),
    A puncture needle (14) protruding in the distal direction from the distal end of the barrel (12) and having a needle tip (15) at the distal end;
    A hollow cylindrical cover member (28, 28a) that is axially displaceable relative to the barrel (12), and in the initial state, the cover member (28, 28a) is at least the puncture needle (14). Covering part of the cover member (28, 28a) relative to the barrel (12) in the proximal direction by being pressed against the puncture target when the puncture needle (14) punctures the puncture target A protective device (20) configured to be displaced and cover the needle tip (15) with the cover member (28, 28a) after puncturing the puncture needle (14) to the puncture target,
    The front end of the cover member (28, 28a) extends in the circumferential direction, and suppresses slipping on the puncture target when the cover member (28, 28a) abuts against the puncture target obliquely. A slip suppression part (30) is provided,
    A syringe (10A to 10F) characterized by the above.
  2.  請求項1記載の注射器(10A~10F)において、
     前記滑り抑制部(30)は、環状に形成されている、
     ことを特徴とする注射器(10A~10F)。
    The syringe (10A-10F) according to claim 1,
    The slip suppression part (30) is formed in an annular shape,
    A syringe (10A to 10F) characterized by the above.
  3.  請求項1又は2記載の注射器(10A、10B)において、
     前記滑り抑制部(30)は、前記カバー部材(28)から径方向外側に突出した突起構造(32、40)を有する、
     ことを特徴とする注射器(10A、10B)。
    The syringe (10A, 10B) according to claim 1 or 2,
    The slip suppression portion (30) has a protruding structure (32, 40) protruding radially outward from the cover member (28).
    The syringe (10A, 10B) characterized by this.
  4.  請求項3記載の注射器(10A、10B)において、
     前記突起構造(32、40)は、前記カバー部材(28)の外周面から突出している、
     ことを特徴とする注射器(10A、10B)。
    The syringe (10A, 10B) according to claim 3,
    The protruding structure (32, 40) protrudes from the outer peripheral surface of the cover member (28).
    The syringe (10A, 10B) characterized by this.
  5.  請求項4記載の注射器(10B)において、
     前記突起構造(40)は、軸方向に並んだ複数の突起(42、44、46)を有する
     ことを特徴とする注射器(10B)。
    The syringe (10B) according to claim 4,
    The protrusion structure (40) has a plurality of protrusions (42, 44, 46) arranged in the axial direction.
  6.  請求項5記載の注射器(10B)において、
     前記複数の突起(42、44、46)において隣り合う突起は、先端側の突起よりも基端側の突起の方が径方向外側に突出している、
     ことを特徴とする注射器(10B)。
    The syringe (10B) according to claim 5,
    Among the plurality of protrusions (42, 44, 46), the protrusions adjacent to each other protrude from the protrusions on the proximal end side toward the radially outer side than the protrusions on the distal end side.
    The syringe (10B) characterized by the above-mentioned.
  7.  請求項3~6のいずれか1項に記載の注射器(10A、10B)において、
     前記突起構造(32、40)は、軸方向に対して垂直な先端面(33、42a)を有する、
     ことを特徴とする注射器(10A、10B)。
    The syringe (10A, 10B) according to any one of claims 3 to 6,
    The protruding structure (32, 40) has a tip surface (33, 42a) perpendicular to the axial direction.
    The syringe (10A, 10B) characterized by this.
  8.  請求項3~7のいずれか1項に記載の注射器(10A、10B)において、
     前記カバー部材(28)は、前記突起構造(32、40)よりも先端側に、先端方向に向かう従って外径が減少する湾曲面(35)を有する
     ことを特徴とする注射器(10A、10B)。
    The syringe (10A, 10B) according to any one of claims 3 to 7,
    The syringe (10A, 10B), wherein the cover member (28) has a curved surface (35) whose outer diameter decreases in the distal direction from the protrusion structure (32, 40) toward the distal end. .
  9.  請求項1又は2記載の注射器(10C~10F)において、
     前記カバー部材(28a)は、カバー部材本体(48)と、前記カバー部材本体(48)の先端部に固定された前記滑り抑制部(30)とを有し、
     前記滑り抑制部(30)は、弾性材料により構成された弾性部材(52a~52d)である、
     ことを特徴とする注射器(10C~10F)。
    The syringe (10C to 10F) according to claim 1 or 2,
    The cover member (28a) includes a cover member main body (48), and the slip suppression portion (30) fixed to a tip end portion of the cover member main body (48).
    The slip suppression part (30) is an elastic member (52a to 52d) made of an elastic material.
    A syringe (10C to 10F) characterized by the above.
  10.  請求項9記載の注射器(10C)において、
     前記弾性部材(52a)は、前記カバー部材本体(48)の先端面に固定されている、
     ことを特徴とする注射器(10C)。
    The syringe (10C) of claim 9,
    The elastic member (52a) is fixed to the front end surface of the cover member body (48).
    A syringe (10C) characterized in that.
  11.  請求項9記載の注射器(10D)において、
     前記弾性部材(52b)は、前記カバー部材本体(48)の前記先端部を外周面から先端面に亘って覆っている、
     ことを特徴とする注射器(10D)。
    The syringe (10D) of claim 9,
    The elastic member (52b) covers the distal end portion of the cover member main body (48) from the outer peripheral surface to the distal end surface.
    The syringe (10D) characterized by this.
  12.  請求項9記載の注射器(10E)において、
     前記弾性部材(52c)は、前記カバー部材本体(48)の先端内周部に設けられた凸部(64)と係合する凹部(66)を有し、前記カバー部材本体(48)の先端部内側に嵌合している、
     ことを特徴とする注射器(10E)。
    The syringe (10E) according to claim 9,
    The elastic member (52c) has a concave portion (66) that engages with a convex portion (64) provided on the inner peripheral portion of the tip of the cover member main body (48), and the tip of the cover member main body (48). Fitted inside the part,
    A syringe (10E) characterized in that.
  13.  請求項9記載の注射器(10F)において、
     前記弾性部材(52d)は、前記カバー部材本体(48)の先端部に設けられた溝部(68)に嵌合し、前記先端部の外周面から突出している、
     ことを特徴とする注射器(10F)。
    The syringe (10F) according to claim 9,
    The elastic member (52d) is fitted into a groove (68) provided at the tip of the cover member main body (48) and protrudes from the outer peripheral surface of the tip.
    The syringe (10F) characterized by this.
  14.  請求項1~13のいずれか1項に記載の注射器(10A~10F)において、
     前記バレル(12)内に摺動可能に挿入されたガスケット(16)と、
     前記ガスケット(16)に連結され又は前記ガスケット(16)に連結可能な押し子(18)と、
     前記バレル(12)と前記ガスケット(16)とにより形成される液室に充填された薬液と、を備える、
     ことを特徴とする注射器(10A~10F)。
    The syringe (10A to 10F) according to any one of claims 1 to 13,
    A gasket (16) slidably inserted into the barrel (12);
    A pusher (18) connected to or connectable to the gasket (16);
    A chemical solution filled in a liquid chamber formed by the barrel (12) and the gasket (16),
    A syringe (10A to 10F) characterized by the above.
PCT/JP2017/012563 2016-03-30 2017-03-28 Syringe WO2017170502A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018508045A JPWO2017170502A1 (en) 2016-03-30 2017-03-28 Syringe

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016067891 2016-03-30
JP2016-067891 2016-03-30

Publications (1)

Publication Number Publication Date
WO2017170502A1 true WO2017170502A1 (en) 2017-10-05

Family

ID=59964609

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2017/012563 WO2017170502A1 (en) 2016-03-30 2017-03-28 Syringe

Country Status (2)

Country Link
JP (1) JPWO2017170502A1 (en)
WO (1) WO2017170502A1 (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11276584A (en) * 1998-03-31 1999-10-12 Shimadzu Corp Syringe without needle
US20040147901A1 (en) * 2002-07-08 2004-07-29 Medical Instill Intradermal delivery device, and method of intradermal delivery
JP2005287676A (en) * 2004-03-31 2005-10-20 Matsushita Electric Ind Co Ltd Medical injection appliance
JP2007136193A (en) * 2005-11-17 2007-06-07 Lifescan Inc Method for lancing dermal tissue target site using cap with revolving body
WO2009119787A1 (en) * 2008-03-28 2009-10-01 テルモ株式会社 Injector
JP2010524646A (en) * 2007-04-23 2010-07-22 エス・アイ・ディ・テクノロジーズ・リミテッド・ライアビリティ・カンパニー Method and apparatus for intradermal injection
JP2012071112A (en) * 2010-08-23 2012-04-12 Becton Dickinson & Co Skin engagement member for use with needle assembly or medical injector
WO2015122884A1 (en) * 2014-02-12 2015-08-20 Abbvie Inc. Self-injection tool with movable needle shroud
JP2015532180A (en) * 2012-10-19 2015-11-09 アムゲン・インコーポレーテッド Improved automatic syringe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0631747U (en) * 1992-10-06 1994-04-26 シエン ツオ チョアン Needle protection cap

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11276584A (en) * 1998-03-31 1999-10-12 Shimadzu Corp Syringe without needle
US20040147901A1 (en) * 2002-07-08 2004-07-29 Medical Instill Intradermal delivery device, and method of intradermal delivery
JP2005287676A (en) * 2004-03-31 2005-10-20 Matsushita Electric Ind Co Ltd Medical injection appliance
JP2007136193A (en) * 2005-11-17 2007-06-07 Lifescan Inc Method for lancing dermal tissue target site using cap with revolving body
JP2010524646A (en) * 2007-04-23 2010-07-22 エス・アイ・ディ・テクノロジーズ・リミテッド・ライアビリティ・カンパニー Method and apparatus for intradermal injection
WO2009119787A1 (en) * 2008-03-28 2009-10-01 テルモ株式会社 Injector
JP2012071112A (en) * 2010-08-23 2012-04-12 Becton Dickinson & Co Skin engagement member for use with needle assembly or medical injector
JP2015532180A (en) * 2012-10-19 2015-11-09 アムゲン・インコーポレーテッド Improved automatic syringe
WO2015122884A1 (en) * 2014-02-12 2015-08-20 Abbvie Inc. Self-injection tool with movable needle shroud

Also Published As

Publication number Publication date
JPWO2017170502A1 (en) 2019-02-07

Similar Documents

Publication Publication Date Title
US11992665B2 (en) Needle cover
US11992666B2 (en) Automatic-locking safety needle covers and methods of use and manufacture
US7976499B2 (en) Automatic injection device
JP5030593B2 (en) Safety shield system for prefilled syringes
CN111790045B (en) Fluid delivery device or set with retractable needle and septum
EP2918301B1 (en) Liquid administration device
KR20140042901A (en) Refill module for an injection device
WO2017073658A1 (en) Grip and syringe assembly
US10709847B2 (en) Retractable needle syringe with unitary propellant release module
EP3270991B1 (en) Retractable blood collection devices
JP6360470B2 (en) Liquid dosing device
JP7523529B2 (en) Needle assembly having needle shield and plug
EP3681569A1 (en) Safety assembly
WO2017170502A1 (en) Syringe
US20200009328A1 (en) Syringe assembly
WO2016152377A1 (en) Catheter assembly
WO2013046867A1 (en) Syringe
EP3659654B1 (en) Needle assembly
JP2019154954A (en) Needle assembly
JP2019154953A (en) Needle assembly

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2018508045

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17775039

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 17775039

Country of ref document: EP

Kind code of ref document: A1